School of Public Health, Fudan University, 130 Dong'an Road, Shanghai 200030, China.
Duke Global Health Institute, Duke University, 310 Trent Drive, Durham, NC 27710, United States.
Health Policy Plan. 2024 May 15;39(5):519-527. doi: 10.1093/heapol/czae022.
Providers have intended and unintended responses to payment reforms, such as China's new case-based payment system, i.e. Diagnosis-Intervention Packet (DIP) under global budget, that classified patients based on the combination of principal diagnosis and procedures. Our study explores the impact of DIP payment reform on hospital selection of patients undergoing total hip/knee arthroplasty (THA/TKA) or with arteriosclerotic heart disease (AHD) from July 2017 to June 2021 in a large city. We used a difference-in-differences approach to compare the changes in patient age, severity reflected by the Charlson Comorbidity Index (CCI), and a measure of treatment intensity [relative weight (RW)] in hospitals that were and were not subject to DIP incentives before and after the DIP payment reform in July 2019. Compared with non-DIP pilot hospitals, trends in patient age after the DIP reform were similar for DIP and non-DIP hospitals for both conditions, while differences in patient severity grew because severity in DIP hospitals increased more for THA/TKA (P = 0.036) or dropped in non-DIP hospitals for AHD (P = 0.011) following DIP reform. Treatment intensity (measured via RWs) for AHD patients in DIP hospitals increased 5.5% (P = 0.015) more than in non-DIP hospitals after payment reform, but treatment intensity trends were similar for THA/TKA patients in DIP and non-DIP hospitals. When the DIP payment reform in China was introduced just prior to the pandemic, hospitals subject to this reform responded by admitting sicker patients and providing more treatment intensity to their AHD patients. Policymakers need to balance between cost containment and the unintended consequences of prospective payment systems, and the DIP payment could also be a new alternative payment system for other countries.
医疗机构对支付改革(如中国基于总额预算的按病种分值付费(DIP)的新诊断相关分组支付方式)有着预期和非预期的反应,该方式根据主要诊断和操作的组合对患者进行分类。我们的研究从 2017 年 7 月到 2021 年 6 月,在一个大城市,探讨了 DIP 支付改革对接受全髋关节/膝关节置换术(THA/TKA)或有动脉粥样硬化性心脏病(AHD)的患者在医院选择上的影响。我们采用了双重差分法,比较了在 2019 年 7 月 DIP 支付改革前后,试点 DIP 医院和非试点 DIP 医院的患者年龄、Charlson 合并症指数(CCI)反映的严重程度以及治疗强度(相对权重(RW))的变化。与非试点 DIP 医院相比,DIP 改革后,两种情况下 DIP 医院和非试点 DIP 医院的患者年龄趋势相似,而患者严重程度的差异增大,因为 DIP 医院的严重程度在 THA/TKA 中增加更多(P=0.036),或在非试点 DIP 医院的 AHD 中下降(P=0.011)。DIP 医院 AHD 患者的治疗强度(通过 RW 测量)在支付改革后增加了 5.5%(P=0.015),比非 DIP 医院增加更多,但 DIP 医院和非 DIP 医院的 THA/TKA 患者的治疗强度趋势相似。在中国引入 DIP 支付改革恰逢疫情之前,实施这一改革的医院通过收治病情较重的患者并增加 AHD 患者的治疗强度做出了反应。政策制定者需要在控制成本和预期支付系统的意外后果之间取得平衡,DIP 支付也可能成为其他国家的一种新的替代支付系统。